FDA approves new drug for migraine sufferers

The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news